“Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S86, https://doi.org/10.25251/skin.2.supp.87.